These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 11445452)

  • 1. Immunity to Bordetella pertussis.
    Mills KH
    Microbes Infect; 2001 Jul; 3(8):655-77. PubMed ID: 11445452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
    Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
    Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal Immunity to
    Argondizo-Correia C; Rodrigues AKS; de Brito CA
    J Immunol Res; 2019; 2019():7134168. PubMed ID: 30882004
    [No Abstract]   [Full Text] [Related]  

  • 4. Serological correlates of immunity to Bordetella pertussis.
    Hewlett EL; Halperin SA
    Vaccine; 1998 Dec; 16(20):1899-900. PubMed ID: 9796040
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.
    Dunne A; Mielke LA; Allen AC; Sutton CE; Higgs R; Cunningham CC; Higgins SC; Mills KH
    Mucosal Immunol; 2015 May; 8(3):607-17. PubMed ID: 25315966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
    Gillard J; van Schuppen E; Diavatopoulos DA
    Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waning and aging of cellular immunity to Bordetella pertussis.
    van Twillert I; Han WG; van Els CA
    Pathog Dis; 2015 Nov; 73(8):ftv071. PubMed ID: 26371178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and preliminary immunobiological characterization of a novel, non-reverting, intranasal live attenuated whooping cough vaccine candidate.
    Cornford-Nairns R; Daggard G; Mukkur T
    J Microbiol Biotechnol; 2012 Jun; 22(6):856-65. PubMed ID: 22573165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement evasion by Bordetella pertussis: implications for improving current vaccines.
    Jongerius I; Schuijt TJ; Mooi FR; Pinelli E
    J Mol Med (Berl); 2015 Apr; 93(4):395-402. PubMed ID: 25686752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.
    Redhead K; Watkins J; Barnard A; Mills KH
    Infect Immun; 1993 Aug; 61(8):3190-8. PubMed ID: 8335349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal pertussis, cocooning and maternal immunization.
    Swamy GK; Wheeler SM
    Expert Rev Vaccines; 2014 Sep; 13(9):1107-14. PubMed ID: 25075629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3.
    Debrie AS; Coutte L; Raze D; Mooi F; Alexander F; Gorringe A; Mielcarek N; Locht C
    Vaccine; 2018 Mar; 36(11):1345-1352. PubMed ID: 29433898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Immune Responses to Pertussis Vaccines.
    Ausiello CM; Mascart F; Corbière V; Fedele G
    Adv Exp Med Biol; 2019; 1183():99-113. PubMed ID: 31342460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.